IL6R and neoplasm: Subsequently, all the factors were down-regulated, and RT-PCR indicated that the expression ratios of seven weeks/five weeks of IL-6, IL-6R, and gp130 in tumor growth decreased by 0.43-fold, 0.47-fold, and 0.33-fold, respectively.